Alpha-lipoic acid inhibits tumor necrosis factor-induced remodeling and weakening of human fetal membranes

Biology of Reproduction

Volumn 80, Issue 4, 2009, Pages 781-787

  Moore, Robert M ^a   Novak, Jillian B ^a   Kumar, Deepak ^a   Mansour, Joseph M ^a   Mercer, Brian M ^b   Moore, John J ^a,c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Division of Neonatology   (United States)

Author keywords

Amnion; Fetal membrane rupture; Fetal membranes; Lipoic acid; Matrix metalloproteinase; MMP9; Parturition; PGE 2; Placenta

Indexed keywords

GELATINASE B; INTERLEUKIN 1BETA; PROSTAGLANDIN F3 ALPHA; THIOCTIC ACID; TUMOR NECROSIS FACTOR;

AMNION; ARTICLE; CELL POPULATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; EPITHELIUM CELL; FETUS MEMBRANE; HUMAN; HUMAN CELL; HUMAN TISSUE; MEMBRANE RUPTURE; MESENCHYME CELL; PRIORITY JOURNAL; WESTERN BLOTTING; ZYMOGRAPHY;

AMNION; CELLS, CULTURED; DINOPROSTONE; DRUG EVALUATION, PRECLINICAL; EPITHELIAL CELLS; EXTRAEMBRYONIC MEMBRANES; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; HUMANS; MATRIX METALLOPROTEINASE 9; MESODERM; PREGNANCY; SHEAR STRENGTH; THIOCTIC ACID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 65249120769     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.108.073205     Document Type: Article

References (46)

1. Menon R. Spontaneous preterm birth, a clinical dilemma: etiologic, pathophysiologic and genetic heterogeneities and racial disparity. Acta Obstet Gynecol Scand 2008; 87:590-600.
2. Parry S, Strauss JF. Premature rupture of the fetal membranes. N Engl J Med 1998; 338:663-670.
3. Pandey V, Jaremko K, Moore RM, Mercer BM, Stetzer B, Kumar D, Fox JM, Mansour JM, Moore JJ. The force required to rupture fetal membranes paradoxically increases with acute in vitro repeated stretching. Am J Obstet Gynecol 2007; 196:165.e1-165.e7.
4. Moore RM, Mansour JM, Redline RW, Mercer BM, Moore JJ. The physiology of fetal membrane rupture: insight gained from the determination of physical properties. Placenta 2006; 27:1037-1051.
5. Menon R, Fortunato SJ. The role of matrix degrading enzymes and apoptosis in rupture of membranes. J Soc Gynecol Investig 2004; 11:427-437.
6. El Khwad M, Stetzer B, Moore RM, Kumar D, Mercer B, Arikat S, Redline RW, Mansour JM, Moore JJ. Term human fetal membranes have a weak zone overlying the lower uterine pole and cervix before onset of labor. Biol Reprod 2005; 72:720-726.
7. El Khwad M, Pandey V, Stetzer B, Mercer BM, Kumar D, Moore RM, Fox J, Redline RW, Mansour JM, Moore JJ. Fetal membranes from term vaginal deliveries have a zone of weakness exhibiting characteristics of apoptosis and remodeling. J Soc Gynecol Investig 2006; 13:191-195.
8. McLaren J, Malak TM, Bell SC. Structural characteristics of term human fetal membranes prior to labour: identification of an area of altered morphology overlying the cervix. Hum Reprod 1999; 14:237-241.
9. Xu P, Alfaidy N, Challis JR. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in human placenta and fetal membranes in relation to preterm and term labor. J Clin Endocrinol Metab 2002; 87:1353-1361.
10. Tsatas D, Baker MS, Rice GE. Differential expression of proteases in human gestational tissues before, during and after spontaneous-onset labour at term. J Reprod Fertil 1999; 116:43-19.
11. Sundaresan M, Yu ZX, Ferrans VJ, Sulciner DJ, Gutkind JS, Irani K, Goldschmidt-Clermont PJ, Finkel T. Regulation of reactive-oxygen- species generation in fibroblasts by Rac1. Biochem J 1996; 318:379-382.
12. Sulciner DJ, Irani K, Yu ZX, Ferrans VJ, Goldschmidt-Clermont P, Finkel T. Rac1 regulates a cytokine-stimulated, redox-dependent pathway necessary for NF-kappaB activation. Mol Cell Biol 1996; 16:7115-7121.
13. Bowie A, O'Neill LA. Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 2000; 59:13-23.
14. Liu ZG. Molecular mechanism of TNF signaling and beyond. Cell Res 2005; 15:24-27.
15. Lappas M, Permezel M, Rice GE. N-Acetyl-cysteine inhibits phospholipid metabolism, proinflammatory cytokine release, protease activity and nuclear factor-kappaB deoxyribonucleic acid-binding activity in human fetal membranes in vitro. J Clin Endocrinol Metab 2003; 88:1723-1729.
16. Steyn PS, Odentaal HJ, Schoeman J, Stander C, Fanie N, Grové D. A randomized, double-blind placebo-controlled trial of ascorbic acid supplementation for the prevention of preterm labor. J Obstet Gynaecol 2003 ; 23:150-155.
17. Rumbold A, Crowther CA. Vitamin C supplementation in pregnancy. Cochrane Database of Syst Rev 2005; 2:CD004072.
18. Selman C, McLaren JS, Meyer C, Duncan JS, Redman P, Collins AR, Duthie GG, Speakman JR. Life-long vitamin C supplementation in combination with cold exposure does not affect oxidative damage or lifespan in mice, but decreases expression of antioxidant protection genes. Mech Ageing Dev 2006; 127:897-904.
19. Lachili B, Hininger I, Faure H, Arnaud J, Richard MJ, Favier A, Roussel AM. Increased lipid peroxidation in pregnant women after iron and vitamin C supplementation. Biol Trace Elem Res 2001; 83:103-110.
20. Kumar D, Moore RM, Elkhwad M, Silver RJ, Moore JJ. Vitamin C exacerbates hydrogen peroxide induced apoptosis and concomitant PGE2 release in amnion epithelial and mesenchymal cells, and in intact amnion. Placenta 2004; 25:573-579.
21. Kumar D, Lundgren DW, Moore RM, Silver RJ, Moore JJ. Hydrogen peroxide induced apoptosis in amnion-derived WISH cells is not inhibited by vitamin C. Placenta 2004; 25:266-272.
22. Reed LJ, DeBusk BG, Gansalus IC, Hornberger CS Jr. Crystalline α-lipoic acid: a catalytic agent associated with pyruvate dehydrogenase. Science 1951; 114:93-94.
23. Biewenga GP, Haenen GR, Bast A. The pharmacology of the antioxidant lipoic acid. Gen Pharmacol 1997; 29:315-331.
24. Packer L, Witt EH, Tritschler HJ. α-Lipoic acid as a biological antioxidant. Free Radic Biol Med 1995; 19:227-250.
25. Bilska A, Wlodek L. Lipoic Acid-drug of the future? Pharmacol Rep 2005; 57:570-577.
26. Smith AR, Shenvi SV, Widlansky M, Suh JH, Hagen TM. Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress. Curr Med Chem 2004; 11:1135-1146.
27. Hu HL, Forsey RJ, Blades TJ, Barratt ME, Parmar P, Powell JR. Antioxidants may contribute in the fight against ageing: an in vitro model. Mech Ageing Dev 2000; 121:217-230.
28. Kumar D, Fung W, Moore RM, Pandey V, Fox J, Stetzer B, Mansour JM, Mercer BM, Redline RW, Moore JJ. Proinflammatory cytokines found in amniotic fluid induce collagen remodeling, apoptosis, and biophysical weakening of cultured human fetal membranes. Biol Reprod 2006; 74:29-34.
29. McLaren J, Taylor DJ, Bell SC. Prostaglandin E(2)-dependent production of latent matrix metalloproteinase-9 in cultures of human fetal membranes. Mol Hum Reprod 2000; 6:1033-1040.
30. Li W, Unlugedik E, Bocking AD, Challis JR. The role of prostaglandins in the mechanism of lipopolysaccharide-induced proMMP9 secretion from human placenta and fetal membrane cells. Biol Reprod 2007; 76:654-659.
31. Arikat S, Novince RW, Mercer BM, Kumar D, Fox JM, Mansour JM, Moore JJ. Separation of amnion from choriodecidua is an integral event to the rupture of normal term fetal membranes and constitutes a significant component of the work required. Am J Obstet Gynecol 2006; 194:211-217.
32. Fortunato SJ, Menon R, Swan KF, Lyden TW. Organ culture of amniochorionic membrane in vitro. Am J Reprod Immunol 1994; 32:184-187.
33. Okita JR, Sagawa N, Casey ML, Snyder JM. A comparison of human amnion tissue and human amnion cells in primary culture by morphological and biochemical criteria. In Vitro 1983; 19:117-126.
34. Casey ML, MacDonald PC. Interstitial collagen synthesis and processing in human amnion: a property of the mesenchymal cells. Biol Reprod 1996; 55:1253-1260.
35. Chow SS, Craig ME, Jones CA, Hall B, Catteau J, Lloyd AR, Rawlinson WD. Differences in amniotic fluid and maternal serum cytokine levels in early midtrimester women without evidence of infection. Cytokine 2008; 4:78-84.
36. Hillier SL, Witin SS, Krohn MA, Watts DH, Kiviat NB, Eschenbach DA. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstet Gynecol 1993; 81:941-948.
37. Xu P, Alfaidy N, Challis JG. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in human placenta and fetal membranes in relation to preterm and term labor. J Clin Endocrinol Metab 2002; 87:1353-1361.
38. Weiss A, Goldman S, Shalev E. The matrix metalloproteinases (MMPS) in the decidua and fetal membranes. Front Biosci 2007; 12:649-659.
39. Kim SS, Romero R, Kim JS, Abbas A, Espinoza J, Kusanovic JP, Hassan S, Yoon BH, Kim CJ. Coexpression of myofibroblast and macrophage markers: novel evidence for an in vivo plasticity of chorioamniotic mesodermal cells of the human placenta. Lab Invest 2008; 88:365-374.
40. Audus KL, Soares MJ, Hunt JS. Characteristics of the fetal/maternal interface with potential usefulness in the development of future immunological and pharmacological strategies. J Pharmacol Exp Ther 2002; 301:402-409.
41. Bauer S, Pollheimer J, Hartmann J, Husslein P, Aplin JD, Knofler M. Tumor necrosis factor-alpha inhibits trophoblast migration through elevation of plasminogen activator inhibitor-1 in first trimester villous explant cultures. J Clin Endocrinol Metab 2004; 89:812-822.
42. Lockwood CJ, Oner C, Uz YH, Kayisli UA, Huang SJ, Buchwalder LF, Murk W, Funai EF, Schatz F. Matrix metalloproteinase 9 (MMP9) expression in preeclamptic decidua and MMP9 induction by tumor necrosis factor alpha and interleukin 1 beta in human first trimester decidual cells. Biol Reprod 2008; 78:1064-1072.
43. Lindström TM, Bennett PR. The role of nuclear factor kappa B in human labour. Reproduction 2005; 130:569-581.
44. Kim HS, Kim HJ, Park KG, Kim YN, Kwon TK, Park JY, Lee KU, Kim JG, Lee IK. a-Lipoic acid inhibits matrix metalloproteinase-9 expression by inhibiting NF-κB transcriptional activity. Exp Mol Med 2007; 39:106-113.
45. 2 synthesis. J Immunol 2005; 176:111-117.
46. Zhang WJ, Wei H, Hagen T, Frei B. α-Lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase/Akt signaling pathway. Proc Natl Acad Sci U S A 2007; 104:4077-4082.